News-Medical.Net on MSN
Immune checkpoint inhibitors can trigger rare immune thrombocytopenia in cancer patients
Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...
Patients with extensive-stage SCLC who received immunochemotherapy before 15:00 hrs exhibited significantly longer PFS, overall survival.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback